Cardiomyopathy Clinical Trial
— VFOfficial title:
Comparison of Ventricular Fibrillation Induction Techniques During Medtronic Implantable Cardioverter Defibrillator Implant
NCT number | NCT02027883 |
Other study ID # | VF Induction |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | January 2011 |
Est. completion date | August 2012 |
Verified date | April 2018 |
Source | Wellmont CVA Heart Institute |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
As the indications for Implantable Cardioverter Defibrillator implantation expand, minimizing
implant time is critical. Also, patients receiving biventricular ICDs are sometimes more
unstable and minimization of sedation time is crucial. Multiple induction attempts, with a
1-Joule shock, can cause disruption in lead position. Therefore limiting the number of
attempts will allow for better lead stability throughout the procedure and a more
straightforward implant process.
Investigator proposes a detailed documentation of success rates from various Ventriculart
Fibrillation induction methods during implant of Medtronic defibrillation capable devices.
Status | Completed |
Enrollment | 100 |
Est. completion date | August 2012 |
Est. primary completion date | August 2012 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - All patients undergoing Medtronic ICD or Cardiac Resynchronization Therapy-Defibrillator implant (initial implant or generator replacement) will be included. Exclusion Criteria: - Any patient who is medically unstable and testing is deemed unsafe by physician will be excluded from this study. |
Country | Name | City | State |
---|---|---|---|
United States | Wellmont CVA Heart Institute | Kingsport | Tennessee |
Lead Sponsor | Collaborator |
---|---|
James Merrill | Medtronic |
United States,
Bardy G, Mehra R, Johnson G, Kudenchuk P, Dolack G, Poole J, Hofer B: Low energy pulsing on the T-wave: A new programming method for intentional, device mediated induction of ventricular fibrillation for defibrillation testing. PACE 15(4, Pt II): 562, 1992.
Bhandari AK, Isber N, Estioko M, Ziccardi T, Cannom DS, Park Y, Lerman RD, Prejean C, Sun GW. Efficacy of low-energy T wave shocks for induction of ventricular fibrillation in patients with implantable cardioverter defibrillators. J Electrocardiol. 1998 Jan;31(1):31-7. — View Citation
Marquis DR Reference Manual, Medtronic, Inc.
Mitchell L, Yee R, Talajic M, Newman D, Sheldon R, Kerr C, Kus T, Boyle A, Canadian Jewel PCD Investigators: Low-energy, T-wave synchronous, interval shock for rapid, reliable ventricular fibrillation induction by an implantable cardioverter defibrllattor. PACE, 17(4, Pt II): 851, 1994.
Swartz J, Stanton M, DeGroot P, Mehra R: Influence of T-wave shock energy on ventricular fibrillation vulnerability in humans. JACC 1995 Conference Abstracts: 214A, 1995.
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Safety Monitoring | Number of participants that were monitored for safety issues, including increased heart rate, blood pressure, decreased oximetry levels, and stable rhythm during the entire procedure. | 2 hours | |
Primary | Sustained Ventricular Fibrillation | The primary endpoint is the successful induction of sustained ventricular fibrillation. | 2 hours | |
Secondary | Factors | Determine if any pre-implant patient demographics are factors impacting T-shock success according to parameter settings. | 2 hours |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 | |
Completed |
NCT02892448 -
Cardiac MRI for Metal on Metal Hip Resurfacing
|
N/A | |
Active, not recruiting |
NCT02537782 -
Myocardial Work and Metabolism in CRT
|
N/A | |
Completed |
NCT02525185 -
Contractile Reserve in Dyssynchrony: A Novel Principle to Identify Candidates for Cardiac Resynchronization Therapy
|
||
Terminated |
NCT01705509 -
The Effects of Ranolazine on CPET Parameters in Ischemic Cardiomyopathy Patients (ERIC)
|
N/A | |
Completed |
NCT00999947 -
Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
|
N/A | |
Completed |
NCT00626028 -
Comparison of Inhaled Nitric Oxide and Oxygen in Participants Reactivity During Acute Pulmonary Vasodilator Testing
|
Phase 3 | |
Recruiting |
NCT00138931 -
Genetics of Cardiovascular and Neuromuscular Disease
|
||
Withdrawn |
NCT02838355 -
Employing End Tidal Capnography in Continuous Flow Ventricular Assist Device Patients
|
N/A | |
Completed |
NCT01085955 -
Investigation in Pregnancy Associate Cardiomyopathy
|
N/A | |
Withdrawn |
NCT00428103 -
Effects of Mitral Valve Repair With the Geoform Ring on Cardiomyopathy
|
N/A | |
Recruiting |
NCT00273637 -
Registry and Survey of Women With Pregnancy Related Cardiomyopathy
|
N/A | |
Completed |
NCT00810550 -
Carotid Ultrasound in the Evaluation of Heart Failure
|
N/A | |
Completed |
NCT04603521 -
Patients' Long-Term Survival of Obstructive Hypertrophic Cardiomyopathy (HCM)
|
||
Enrolling by invitation |
NCT03057561 -
Efficacy of Dotarem® (Gd-DOTA) Versus Gadovist® (Gd-DO3A-butrol) for Late Gadolinium Enhancement Cardiac Magnetic Resonance
|
N/A | |
Completed |
NCT00027170 -
Technical Development of Cardiovascular Magnetic Resonance Imaging
|
||
Not yet recruiting |
NCT02917395 -
Evaluate the Efficacy of Disopyramide Therapy in Hypertrophic Obstructive Cardiomyopathy Patients
|
N/A | |
Completed |
NCT02164721 -
Multicenter Automatic Defibrillator Implantation Trial - Chemotherapy-Induced Cardiomyopathy
|
N/A | |
Completed |
NCT02270840 -
Budapest Upgrade CRT Study (Version 009-4.1)
|
N/A | |
Completed |
NCT02331264 -
Cardiac Assessment of Patients With Hip Implants
|
N/A |